A bio-tech company shaping the future of marine antifouling coatings

We are the developers of Selektope - an active antifouling agent that repels barnacles from ships.

This is I-Tech AB

I-Tech is a Nasdaq First North Growth Market-listed bio-technology company [TICKER:ITECH] based in  Sweden. We develop, market and sell the performance ingredient, Selektope® for use in marine antifouling coatings.

Our vision is to establish Selektope® as the leading technology to prohibit marine growth in an effective and sustainable way.

About I-Tech
CORPORATE CONTACTS
Markus 272 × 232

Markus Jönsson

CEO
markus.jonsson@i-tech.se

Magnus Henell

Magnus Henell

CFO & Head of Operations
magnus.henell@i-tech.se

Monica 272 × 232

Monica Kettelhoit

Office Manager
monica.kettelhoit@i-tech.se

Jennifer Ardin, Marketing, Brand and Relations Manager (2) (1)

Jennifer Ardin

Marketing, Brand & Relations Manager
jennifer.ardin@i-tech.se

Selektope logo light

Its powerful, repellent effect on barnacles keeps the ship's hull clean.

Visit selektope.com
Latest news

Show all

2025

2025-02-06 08:00 I-Tech AB (publ) (ticker: ITECH) publish the Year-end report for 2024 Regulatory MAR
” Topline sales sprint in the last quarter crowns a successful year .”
2025-01-30 08:30 I-Tech AB signs supply and license agreement with major Asian-based paint company
Mölndal, Sweden – I-Tech AB (publ) [TICKER: ITECH], the innovative biotechnology company behind the...
2025-01-23 08:30 I-Tech awarded DI Gasell Company
I-Tech AB, the company behind the groundbreaking antifouling technology Selektope, has been named a DI...

Selektope® - ECHA Consultation: Thank you for contributing

We have reached the final submission date of the public consultation to protect our waterways and ensure a sustainable future.

We are grateful for the huge amount of support.

Read more

The European Chemicals Agency (ECHA) is an agency of the EU working for the safe use of chemicals. Biocides are approved by stringent regulatory schemes across different geographies. In the EU, all biocides undergo an extensive approval process under the EU Biocidal Products Regulation.

ECHA is considering the renewal of Medetomidine, the crucial component of our antifouling product, Selektope. If not approved, Selektope's future in the EU market is at risk.

Latest Presentation

Show all

February 6, 2025

I-Tech Year-end report 2024

Markus Jönsson, CEO, and Magnus Henell, CFO & Director of Operations, will present Year-end report 2024 and engage in a live Q&A session with the audience.

(47 minutes)

Investor Communications

Sign up here to get the latest press releases and financial reports from I-Tech AB directly to your inbox.